載入...

Lenalidomide therapy in treatment refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare

BACKGROUND: Lenalidomide is a thalidomide analogue that may serve as an adjunctive therapy for treatment refractory cutaneous lupus erythematosus (CLE). OBJECTIVES: We evaluate the use of lenalidomide in CLE and describe the skin and circulating leukocyte profile of treatment refractory patients bef...

全面介紹

Na minha lista:

書目詳細資料
Main Authors:	Braunstein, I, Goodman, NG, Rosenbach, M, Okawa, J, Shah, A, Krathen, M, Kovarik, CL, Luning Prak, E, Werth, VP
格式:	Artigo
語言:	Inglês
出版:	2011
主題:	Article
在線閱讀:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3306524/ https://ncbi.nlm.nih.gov/pubmed/21821308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2011.01.015
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

Lenalidomide therapy in treatment refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare

相似書籍